[Elsevier] Xylazine*s 百 relatively potent opioid agonist activity is not shared with other FDA-approved 汐2-adrenergic agonists

alywosonhj Post time 3 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-25 04:16
Reward10points

journalㄩThe Journal of Pharmacology and Experimental Therapeutics

AuthorsㄩXi-Ping Huang; Brian E. Krumm; Madigan L. Bedard; Zoe A. McElligott; Bryan L. Roth

Published dateㄩ2026-6-

DOIㄩ10.1016/j.jpet.2026.104969

PDF linkㄩhttps://www.sciencedirect.com/sc ... 022356526011687/pdf

Article linkㄩhttps://doi.org/10.1016/j.jpet.2026.104969

Article SourceㄩElsevier BV


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
scihubtt Post time 3 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list